Estrogen-Related Receptor Alpha Modulates Lactate Dehydrogenase Activity in Thyroid Tumors

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Mirebeau Prunier, Delphine ^a,b,c   Le Pennec, Soazig ^a,b   Jacques, Caroline ^a,b   Fontaine, Jean Fred ^d   Gueguen, Naig ^c   Boutet Bouzamondo, Nathalie ^a,b   Donnart, Audrey ^a   Malthièry, Yves ^a,b,c   Savagner, Frédérique ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RELATED RECEPTOR ALPHA; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME 1; LACTATE DEHYDROGENASE ISOENZYME 5; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL METABOLISM; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LACTATE DEHYDROGENASE A GENE; LACTATE DEHYDROGENASE B GENE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYROID CARCINOMA; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOLYSIS; HUMANS; L-LACTATE DEHYDROGENASE; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN; THYROID NEOPLASMS;

EID: 84874920160     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058683     Document Type: Article

References (39)

1. Zhang Y, Ma K, Sadana P, Chowdhury F, Gaillard S, et al. (2006) Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J Biol Chem 281: 39897-39906.
2. Schreiber SN, Emter R, Hock MB, Knutti D, Cardenas J, et al. (2004) The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis. Proc Natl Acad Sci U S A 101: 6472-6477.
3. Sladek R, Bader JA, Giguere V, (1997) The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Mol Cell Biol 17: 5400-5409.
4. Cai Q, Lin T, Kamarajugadda S and Lu J (2012) Regulation of glycolysis and the Warburg effect by estrogen-related receptors. Oncogene.
5. Nie Y, Wong C, (2009) Suppressing the activity of ERRalpha in 3T3-L1 adipocytes reduces mitochondrial biogenesis but enhances glycolysis and basal glucose uptake. J Cell Mol Med 13: 3051-3060.
6. Mirebeau-Prunier D, Le Pennec S, Jacques C, Gueguen N, Poirier J, et al. (2010) Estrogen-related receptor alpha and PGC-1-related coactivator constitute a novel complex mediating the biogenesis of functional mitochondria. Febs J 277: 713-725.
7. Dufour CR, Wilson BJ, Huss JM, Kelly DP, Alaynick WA, et al. (2007) Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab 5: 345-356.
8. Handschin C, Spiegelman BM, (2006) Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 27: 728-735.
9. He X, Sun C, Wang F, Shan A, Guo T, et al. (2012) Peri-implantation lethality in mice lacking the PGC-1-related coactivator protein. Dev Dyn 241: 975-983.
10. Markert CL, Shaklee JB, Whitt GS, (1975) Evolution of a gene. Multiple genes for LDH isozymes provide a model of the evolution of gene structure, function and regulation. Science 189: 102-114.
11. Swiderek K, Paneth P, (2011) Differences and similarities in binding of pyruvate and L-lactate in the active site of M4 and H4 isoforms of human lactate dehydrogenase. Arch Biochem Biophys 505: 33-41.
12. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, et al. (2010) Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 107: 2037-2042.
13. Gatenby RA, Gillies RJ, (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899.
14. Kim JH, Kim EL, Lee YK, Park CB, Kim BW, et al. (2011) Decreased lactate dehydrogenase B expression enhances claudin 1-mediated hepatoma cell invasiveness via mitochondrial defects. Exp Cell Res 317: 1108-1118.
15. Zha X, Wang F, Wang Y, He S, Jing Y, et al. (2011) Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis. Cancer Res 71: 13-18.
16. Zielke A, Tezelman S, Jossart GH, Wong M, Siperstein AE, et al. (1998) Establishment of a highly differentiated thyroid cancer cell line of Hurthle cell origin. Thyroid 8: 475-483.
17. Jacques C, Fontaine JF, Franc B, Mirebeau-Prunier D, Triau S, et al. (2009) Death-associated protein 3 is overexpressed in human thyroid oncocytic tumours. Br J Cancer 101: 132-138.
18. Schmittgen TD, Lee EJ, Jiang J, (2008) High-throughput real-time PCR. Methods Mol Biol 429: 89-98.
19. Hutter E, Renner K, Pfister G, Stockl P, Jansen-Durr P, et al. (2004) Senescence-associated changes in respiration and oxidative phosphorylation in primary human fibroblasts. Biochem J 380: 919-928.
20. Loiseau D, Chevrollier A, Verny C, Guillet V, Gueguen N, et al. (2007) Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease. Ann Neurol 61: 315-323.
21. Dumont JE, (1962) Pyruvate oxidation in thyroid tissue. Biochim Biophys Acta 56: 382-385.
22. Tyler DD, Gonze J, Lamy F, Dumont JE, (1968) Influence of mitochondrial inhibitors on the respiration and energy-dependent uptake of iodide by thyroid slices. Biochem J 106: 123-133.
23. DeBerardinis RJ, (2008) Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet Med 10: 767-777.
24. Giguere V, (2008) Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev 29: 677-696.
25. Koppenol WH, Bounds PL, Dang CV, (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 11: 325-337.
26. Eichner LJ, Perry MC, Dufour CR, Bertos N, Park M,et al. miR-378(*) mediates metabolic shift in breast cancer cells via the PGC-1beta/ERRgamma transcriptional pathway. Cell Metab 12: 352-361.
27. Zu XL, Guppy M, (2004) Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun 313: 459-465.
28. Jose C, Bellance N, Rossignol R, (2010) Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochim Biophys Acta 1807: 552-561.
29. Charest-Marcotte A, Dufour CR, Wilson BJ, Tremblay AM, Eichner LJ, et al. (2010) The homeobox protein Prox1 is a negative modulator of ERR{alpha}/PGC-1{alpha} bioenergetic functions. Genes Dev 24: 537-542.
30. Downer J, Sevinsky JR, Ahn NG, Resing KA, Betterton MD, (2006) Incorporating expression data in metabolic modeling: a case study of lactate dehydrogenase. J Theor Biol 240: 464-474.
31. Quistorff B, Grunnet N, (2011) The isoenzyme pattern of LDH does not play a physiological role; except perhaps during fast transitions in energy metabolism. Aging (Albany NY) 3: 457-460.
32. Souza EC, Ferreira AC, Carvalho DP, (2011) The mTOR protein as a target in thyroid cancer. Expert Opin Ther Targets 15: 1099-1112.
33. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, et al. (2007) mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450: 736-740.
34. Bianco S, Lanvin O, Tribollet V, Macari C, North S, et al. (2009) Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation. J Biol Chem 284: 23286-23292.
35. Vercauteren K, Gleyzer N, Scarpulla RC, (2009) Short hairpin RNA-mediated silencing of PRC (PGC-1-related coactivator) results in a severe respiratory chain deficiency associated with the proliferation of aberrant mitochondria. J Biol Chem 284: 2307-2319.
36. Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, et al. (2003) Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer 89: 877-885.
37. Koukourakis MI, Giatromanolaki A, Simopoulos C, Polychronidis A, Sivridis E, (2005) Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer. Clin Exp Metastasis 22: 25-30.
38. Vora S, Halper JP, Knowles DM, (1985) Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation- and progression-linked discriminants of malignancy. Cancer Res 45: 2993-3001.
39. Sanchez-Martinez C, Aragon JJ, (1997) Analysis of phosphofructokinase subunits and isozymes in ascites tumor cells and its original tissue, murine mammary gland. FEBS Lett 409: 86-90.